Control-IQ Technology in the Real World: The First 30 Days

被引：0
|
作者：
Mueller, Lars
Constantin, Alexandra
Singh, Harsimran
Habif, Stephanie
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-95-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
95-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology
    Pinsker, Jordan E.
    Mueller, Lars
    Constantin, Alexandra
    Leas, Scott
    Manning, Michelle
    McElwee Malloy, Molly
    Singh, Harsimran
    Habif, Steph
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (02) : 120 - 127
  • [2] Long-Term Glycemic Control in Adult Participants Using Control-IQ Technology: Real-World Evidence
    Graham, Rishi
    Singh, Harsimran
    Alencar, Gabriel
    Mueller, Lars
    Manning, Michelle L.
    White, Kirstin N.
    Wheatcroft, Alex
    Carmelo, Karen
    Aronoffspencer, Eliah S.
    Habif, Stephanie
    Pinsker, Jordan E.
    [J]. DIABETES, 2022, 71
  • [3] One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology
    Breton, Marc D.
    Kovatchev, Boris P.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (09) : 601 - 608
  • [4] Real-World Use of Control-IQ Technology is Associated with a Lower Rate of Severe Hypoglycemia and Diabetic Ketoacidosis Than Historical Data: Results of the Control-IQ Observational (CLIO) Prospective Study
    Graham, Rishi
    Mueller, Lars
    Manning, Michelle
    Habif, Steph
    Messer, Laurel H.
    Pinsker, Jordan E.
    Aronoff-Spencer, Eliah
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, : 24 - 32
  • [5] Real-World Use of Control-IQ Technology Is Associated with a Lower Rate of Severe Hypoglycemia and Diabetic Ketoacidosis Than Historical Data: Results of the Control-IQ Observational (CLIO) Prospective Study
    Graham, Rishi
    Mueller, Lars
    Manning, Michelle
    Habif, Steph
    Messer, Laurel H.
    Pinsker, Jordan E.
    Aronoff-Spencer, Eliah
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2024, 26 (01) : 24 - 32
  • [6] Efficacy of Control-IQ Technology in a General Endocrine Clinic
    Usoh, Chinenye O.
    Price, Catherine
    Johnson, Crystal Paige
    Speiser, Jaime L.
    Aloi, Joseph A.
    [J]. ENDOCRINE PRACTICE, 2023, 29 (01) : 29 - 32
  • [7] Real-world use of Control-IQ™ technology automated insulin delivery in pregnancy: A case series with qualitative interviews
    Wang, Xinye Serena
    Dunlop, Amy D.
    McKeen, Julie A.
    Feig, Denice S.
    Donovan, Lois E.
    [J]. DIABETIC MEDICINE, 2023, 40 (06)
  • [8] Control-IQ Technology Positively Impacts Patient Reported Outcome Measures and Glycemic Control in Youth with Type 1 Diabetes in a Real-World Setting
    Zuijdwijk, Caroline
    Courtney, Jennilea
    Mitsakakis, Nicholas
    Hayawi, Lamia
    Sutherland, Stephanie
    Newhook, Dennis
    Ahmet, Alexandra
    Goldbloom, Ellen B.
    Khatchadourian, Karine
    Lawrence, Sarah
    [J]. PEDIATRIC DIABETES, 2023, 2023
  • [9] Therapy Settings Associated with Optimal Outcomes for t:slim X2 with Control-IQ Technology in Real-World Clinical Care
    Messer, Laurel H.
    Breton, Marc D.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (12) : 877 - 882
  • [10] Real-World Evaluation of Glycemic Outcomes by Prior Therapy for People with Type 1 and Type 2 Diabetes Onboarding to Control-IQ Technology
    Morberg, John W.
    Singh, Harsimran
    Mcelwee-Malloy, Molly
    Habif, Stephanie
    Constantin, Alexandra
    [J]. DIABETES, 2021, 70
12345